Advertisement
Glucose metabolism and weight are associated with marrow fat behavior

Marrow Fat May Affect Bone Mass After Roux-en-Y Gastric Bypass

0
Negative independent association seen for marrow fat and bone mineral density changes
For women undergoing hysterectomy

History of C-Section Ups Risk of Complications in Hysterectomy

0
Women with previous C-section have increased odds of reoperation, peri-, post-op complications
Myocardial injury occurs frequently following transfemoral transcatheter aortic valve replacement

Myocardial Injury Depends on Valve Type in Transfemoral TAVR

0
But extent of cardiac biomarker elevation does not predict mortality after transfemoral TAVR
For women undergoing cesarean section

Wound Complication Rate for C-Section Varies With Suture Type

0
Reduced complications with poliglecaprone 25 versus polyglactin 910 for women undergoing C-section
Characteristics unrelated to allograft quality are associated with later acceptance in the deceased donor kidney match-run

Factors Unrelated to Allograft Quality Tied to Organ Turndown

0
Holiday or weekend procurement, shorter donor stature, location of procurement tied to later acceptance
Patients undergoing Roux-en-Y gastric bypass with diabetes have reduced mortality compared with matched controls

Mortality Down Only for Gastric Bypass Patients With Diabetes

0
RYGB patients without diabetes did not have significantly improved mortality compared to controls
Strategies can help to prevent medical practice billing errors

Guidance Provided for Preventing Practice Billing Errors

0
Practices should have a compliance plan and policy and someone responsible for enforcing it

More Than Two-Thirds of Post-Op Patients Have Unused Opioids

0
Further, patients report low rates of proper disposal of unused opioids

Reconstruction Method in Gastric CA Surgery Affects Bone Density

0
Billroth-I reconstruction better than Roux-en-Y for preventing bone mineral density loss

ABO Incompatible Dual Graft Living Donor Liver Transplant Viable

0
High graft survival at one-, three-, five-years; no significant difference for ABO compatible, incompatible